News Article | April 21, 2017
Looking for a reliable rental service for Bose L1 Compact Portable Line Array Systems, Bose L1 Model 1S Single B1 Bass, or Bose B1 Bass Module?
News Article | May 3, 2017
Microsoft's new Windows 10 S operating system will power a host of affordable laptops from HP, Acer, Dell and others, starting at just $189. Windows 10 S is Microsoft's answer to Google's Chrome OS and aims to challenge Chromebooks to take over the classroom. Microsoft unveiled its own Surface Laptop running Windows 10 S, launching at $999, but the company also teamed up with other PC makers to offer far more affordable options. Eight affordable laptops running the education-focused Windows 10 S will go on sale soon, with prices ranging from $189 to $299. Windows 10 S is a leaner and more locked-down version of Windows 10, allowing users to install apps only from the Windows Store unless they upgrade to Windows 10 Pro. Acer and HP are the first Microsoft hardware partners to launch Windows 10 S laptops, introducing cheaper versions of existing laptops that offer virtually identical specs as the original models, but with the new OS on board. HP is offering a Windows 10 S version of its rugged ProBook x360 Education Edition, which sports an 11.6-inch display with a resolution of 1,366 x 768 pixels, an Intel Celeron processor, 4 GB of RAM and 64 GB of storage. The regular version typically starts at $329 with full Windows 10, but the Windows 10 S version costs $299. Acer, meanwhile, announced a new variant of its TravelMate Spin B1, a convertible laptop with an 11.6-inch 1080p touchscreen display, a stylus, Intel Celeron processor, 4 GB of RAM and 64 GB of storage. The existing version of the device costs $399.99, but the Windows 10 S model costs $299. Both laptops will go on sale later this month, running Windows 10 S out of the box. While Microsoft's own Surface Laptop is arguably more powerful and slick, it's such cheap options from hardware partners that will challenge Chromebooks to the core. Affordable laptops running Google's lightweight Chrome OS have become increasingly popular in schools, so the $999 Surface Laptop might be too expensive to take on Chromebooks. Cheaper Windows 10 S laptops starting at $189, however, might be just what Microsoft needs to give Google a run for its money on the education front. HP and Acer are just the first ones to announce new Windows 10 S laptops, but other hardware partners will offer even cheaper options. Microsoft also lists a new Dell Latitude 3189, Asus VivoBook Flip TP203, HP Stream 11 Pro, Asus VivoBook E201, Samsung Notebook M, and Toshiba Altair ME+, all of which will run the education-focused Windows 10 S. The lineup mainly comprises of a mix of existing models now running the new OS, and refreshed models listed as "coming soon." The common denominator between these affordable Windows 10 S laptops is the specs, as all models feature 11.6-inch displays, Intel Celeron processors, 4 GB of RAM and 64 GB of storage. With such similar specs, it will ultimately come down to design and form factor, as some may prefer a 2-in-1 device while others would rather go for a notebook. Would you buy any of these Windows 10 S laptops? If so, which one? Let us know in the comments section below. © 2017 Tech Times, All rights reserved. Do not reproduce without permission.
News Article | March 24, 2017
A doctor from the Eastern Virginia Medical School in Norfolk, Virginia, believes he has found a potential cure for sepsis - a common and often fatal disease - in the unlikeliest place: the ordinary vitamin C. Dr. Paul Marik says he already treated roughly 150 patients, of which only one succumbed to sepsis. His remedy includes an infusion of vitamin C, along with low doses of hydrocortisone and thiamine (or vitamin B1). After administering his experimental treatment to 47 of his patients, Marik recorded the results in a paper, featured in the online edition of the journal Chest. According to his study, only four of those patients died in the hospital - because of underlying diseases, not sepsis - as opposed to 19, from an equally numbered group of patients treated before he started using the new remedy. Sepsis is an autoimmune disease caused by an overwhelming immune response to infection, and arises when chemicals released by the immune system to fight the infection trigger widespread inflammation throughout the body. This reaction produces blood clots and ruptured blood vessels, leading to impaired blood flow and poor circulation of nutrients and oxygen to the major organs. In severe cases, sepsis can cause organ failure and septic shock. According to the Centers for Disease Control and Prevention, sepsis is typically caused by Staphylococcus aureus, Streptococcus, and E.coli infections. Common symptoms of sepsis resemble other conditions, making it difficult to diagnose in its initial stages, and include fever, chills, rapid breathing and heart rate, rash, confusion, and disorientation. The National Institute of General Medical Sciences reports this severe condition affects more than a million Americans annually, claiming the lives of 28 to 50 percent of them. What makes vitamin C so potent in treating inflammation is the antioxidant's capacity to influence the immune response when it is administered intravenously, as opposed to oral tablets. Marik describes his first patient case treated with the vitamin C infusion two years ago as extremely severe and in desperate need of a creative approach. The patient, a 48-year-old woman, was on the brink of death, suffering from multiple organ failure. Inspired by a previous study from researchers at Virginia Commonwealth University in Richmond, which reported a moderate success of intravenous vitamin C as therapy for sepsis, Marik decided to adapt the treatment. He came up with his own version by adding a mixture of thiamine and corticosteroids - linked in prior research to the treatment of sepsis and septic shock. His remedy managed to save his patient's life and therefore Marik continued to successfully administer it in the following sepsis cases he encountered. The medical community received Marik's study with cautious optimism, since his research didn't follow the standard protocol for assessing potential new treatments. The required procedure involves a randomized double-blind placebo control study, which is yet to be undertaken. Hundreds of other attempts to find an effective treatment for sepsis have been met with failure in follow-up research. Nevertheless, Dr. Craig Coopersmith, from Emory University School of Medicine, believes these results could mean a very important breakthrough pending corroboration, especially considering the high mortality rate associated with sepsis. "If it turns out in further studies that this is true, and we can validate it, then this will be an unbelievably huge deal," he says. © 2017 Tech Times, All rights reserved. Do not reproduce without permission.
News Article | May 2, 2017
Microsoft has officially announced Windows 10 S today. It’s a new lightweight version of Windows 10 that’s going to run on cheap hardware. It only runs sandboxed apps from the Windows Store and does have the ability to be upgraded to a full version of Windows. Many PC manufacturers will make their own Windows 10 S computers. HP and Acer are the first to unveil their new Windows 10 S machines. HP and Acer have basically launched cheaper versions of their existing laptops that now run Windows 10 S. These notebooks are almost identical to their existing models but run the new operating system. Both are priced at $299.HP’s ProBook x360 Education Edition is a rugged notebook that features a 1366×768 pixel resolution 11.6 inch display with an Intel Celeron processor coupled with 4GB of RAM and 64GB of storage.With full Windows 10, this notebook costs $329 but HP is currently selling it for $299 with Windows 10 S.Acer is selling a new version of the TravelMate Spin B1 Convertible for $299. I Remember when convertible notebooks were considered a luxury? That's especially true for convertibles that have four different modes: laptop, stand, tent, and tablet. It was also considered ... The TravelMate Spin B1 is Acer's first Windows 10 S laptop Microsoft's newest Surface laptop and shiny new Windows 10 S operating system weren't the only highlights of the company's Education event in New York on Tuesday. Acer ... Microsoft has officially announced Windows 10 S today. It’s a new lightweight version of Windows 10 that’s going to run on cheap hardware. It only runs sandboxed apps from the ... HP and Acer are the first two hardware partners to announce laptops running Windows 10 S, the new locked-down version of Windows meant for schools. The two companies are announcing ...
News Article | April 17, 2017
Embien Technologies proudly announces the expansion of eStorm series with the launch of eStorm-B1 an automotive ready BLE Module. Powered by industry leading SoC from NXP, the module is expected to transform low power connectivity in the Automotive industry. Madurai, India, April 15, 2017 --( Speaking at the launch, Saravana Pandian Annamalai, CEO of Embien said “While BLE has become the most preferred connectivity technology for the CE market; automotive domain was lagging behind for want of readymade modules ready to meet its stringent requirements. Today eStorm-B1 becomes the first automotive ready module to be powered by NXP giving a huge time to market advantage for Automotive OEM’s.” Embien sees a huge market potential with eStorm-B1 as the industry is looking for low-cost smart phone connectivity with cars and bikes to provide a in-depth view of the internals of the automotive unit to the user. Embien’s eStorm-B1 is ready to deploy model with which BLE connectivity can be added to existing design on the go via multiple host interface options available. NXP KW31Z BLE SoC in the module integrates MCU with ARM Cortex – M0+ Core, 512KB flash memory and 128KB SRAM for processing. As an ultra low power consuming device it finds its applications in Industrial automation, Healthcare devices, Wireless sensor networks, etc. With the features like separate stack availability for I2C, SPI, UART and CAN connectivity, AES-128 algorithm and OTA programming support, eStorm-B1 enables the user to build smart and secured devices for IoT applications. For more details visit http://www.embien.com/estorm-b1-automotive-ble-module About Embien: Embien Technologies is a technology solution provider catering to automotive and industrial automation, healthcare and consumer segments. Targeting IVI Systems and Connected Systems, Embien also offers embedded software and product development support including Virtualization, Boot time reduction, Linux, Android OS Customization, Theming and driver development services etc.Embien offers a series of low cost, low power embedded platforms based on ARM MCUs under the brand eStorm. As a new addition to this series, today eStorm-B1 module is launched specifically targeted for the automotive segment. Madurai, India, April 15, 2017 --( PR.com )-- Embien offers a series of low cost, low power embedded platforms based on ARM MCUs under the brand eStorm. As a new addition to this series, today eStorm-B1 module is launched specifically targeted for the automotive segment.Speaking at the launch, Saravana Pandian Annamalai, CEO of Embien said “While BLE has become the most preferred connectivity technology for the CE market; automotive domain was lagging behind for want of readymade modules ready to meet its stringent requirements. Today eStorm-B1 becomes the first automotive ready module to be powered by NXP giving a huge time to market advantage for Automotive OEM’s.” Embien sees a huge market potential with eStorm-B1 as the industry is looking for low-cost smart phone connectivity with cars and bikes to provide a in-depth view of the internals of the automotive unit to the user.Embien’s eStorm-B1 is ready to deploy model with which BLE connectivity can be added to existing design on the go via multiple host interface options available. NXP KW31Z BLE SoC in the module integrates MCU with ARM Cortex – M0+ Core, 512KB flash memory and 128KB SRAM for processing. As an ultra low power consuming device it finds its applications in Industrial automation, Healthcare devices, Wireless sensor networks, etc.With the features like separate stack availability for I2C, SPI, UART and CAN connectivity, AES-128 algorithm and OTA programming support, eStorm-B1 enables the user to build smart and secured devices for IoT applications.For more details visit http://www.embien.com/estorm-b1-automotive-ble-moduleAbout Embien:Embien Technologies is a technology solution provider catering to automotive and industrial automation, healthcare and consumer segments. Targeting IVI Systems and Connected Systems, Embien also offers embedded software and product development support including Virtualization, Boot time reduction, Linux, Android OS Customization, Theming and driver development services etc.Embien offers a series of low cost, low power embedded platforms based on ARM MCUs under the brand eStorm. As a new addition to this series, today eStorm-B1 module is launched specifically targeted for the automotive segment. Click here to view the list of recent Press Releases from Embien Technologies India Private Limited
News Article | April 24, 2017
Global Allergic Rhinitis Information, by treatment (steroids, antihistamines, decongestants, eye drops, nasal sprays, allergy shots, SLIT), by distribution channels (hospitals, clinics, pharmacies and others) - Forecast to 2022Pune, India - April 24, 2017 /MarketersMedia/ — Market Highlights: Allergic rhinitis is a chronic inflammatory disease affecting the nasal cavity which occurs when a person breathe in something he is allergic to. This disease affects almost every age group. The symptoms include itchy nose/mouth/eyes, problems with smell, runny nose, sneezing, watery eyes. Allergic rhinitis is typically triggered by environmental allergens such as pollen, pet hair, dust, or mold. Inherited genetics and environmental exposures mainly contribute to the development of allergies. Rising incidences of allergic rhinitis, over exposure to the animals or pets, rise in the pollution are some of the key factor responsible for the growth of the global allergic rhinitis market. The market for allergic rhinitis is growing rapidly. Major Key Players • Alcon Inc. • Array BioPharma Inc • AstraZeneca • Dainippon Sumitomo Pharma Co. Ltd. • Genentech Inc. • GlaxoSmithKline PLC • Hisamitsu Pharmaceutical Co. Inc • Meda Pharmaceuticals • Merck • Novartis AG • Nektar Therapeutics • Sanofi • Stallergenes S.A. Request a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/1547 Intended Audience • Anti-allergy drugs manufacturers • Anti-allergy drugs suppliers • Research and Development (R&D) Companies • Government Research Laboratories • Independent Research Laboratories • Government and Independent Regulatory Authorities • Market Research and Consulting Service Providers • Medical Research Laboratories • Academic Medical Institutes and Universities The report for Global Allergic Rhinitis Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. Taste the market data and market information presented through more than 50 market data tables and figures spread in 85 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Allergic Rhinitis Market Research Report- Forecast To 2022” Browse Full Report Details @ https://www.marketresearchfuture.com/reports/allergic-rhinitis-market Study Objectives Allergic Rhinitis Market: • To provide detailed analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the allergic rhinitis market • To provide insights about factors affecting the market growth • To analyze the allergic rhinitis market based on various factors- price analysis, supply chain analysis, porters five force analysis etc. • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa. • To provide country level analysis of the market with respect to the current market size and future prospective • To provide country level analysis of the market for segments by treatment, distribution channels and its sub-segments. • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global allergic rhinitis market. Make an Enquiry @ https://www.marketresearchfuture.com/enquiry/1547 Market Segments: Segmentation by Treatment • Steroids • Antihistamines • Decongestants • Eye Drops • Nasal Sprays • Allergy Shots • SLIT Segmentation by distribution channels • Hospitals • Clinics • Pharmacies The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions. Browse Related Reports:- Global Thymus Cancer Information, by types (type A, type AB, type B1, type B2, type B3 and thymic carcinoma), by treatment (surgery, radiotherapy, chemotherapy and others) By care centers (Hospitals, Clinics, Diagnostic centers, Research laboratories and others) - Forecast to 2024 https://www.marketresearchfuture.com/reports/thymus-cancer-market About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Contact Info:Name: Akash AnandEmail: firstname.lastname@example.orgOrganization: Market Research FutureAddress: Hadapsar Pune, India - 411028Phone: +1 646 845 9312Source URL: http://marketersmedia.com/allergic-rhinitis-market-positive-long-term-growth-outlook-2016-2022/189524For more information, please visit https://www.marketresearchfuture.com/reports/allergic-rhinitis-marketSource: MarketersMediaRelease ID: 189524
News Article | April 24, 2017
The doctor assured Fishman he wasn't alone. Studies show almost half the population is low in vitamins B12 and D, and 25 percent in vitamin B6 – a figure that climbs to 75 percent for women taking birth control pills. And while vitamin-deficiency is common, many people never even realize they're suffering from it. Once Fishman began taking the vitamins recommended by his doctor, his energy levels soared. It was astounding to him how simple the solution had been. This experience sparked the idea to simplify the vital, but oft-forgotten, task of vitamin-taking by combining it with a universal morning ritual: coffee. "I spent years feeling lethargic and unproductive and all it took to feel better was a daily dose of vitamins," said Fishman. "I've always started my day with coffee and when vitamins became part of my routine, it inspired the concept of VitaCup." Fishman began consulting with doctors and registered dieticians, and later met Roastmaster Jeff McIntosh, a fifth-generation coffee grower with Intelligent Blends, a private-label gourmet coffee brand in San Diego. Determined to achieve a rich, quality taste and smooth finish, he experimented with countless ingredients before launching VitaCup. VitaCup pods contain coffee from Fair Trade sources in regions of South and Central America. Each roast features the brand's signature vitamin blend of B1, B5, B6, B9 (folic acid), B12, D3, and antioxidants. The Green Tea adds a powerful combination of Matcha and Moringa to the mix. All of the products are vegan, and free of gluten, dairy and soy. Reducing waste and minimizing the carbon footprint is a chief component of the company's mission; the pods are fully recyclable and produced in a LEED-certified facility. VitaCup employs nitrogen-packing to vacuum-seal each pod, which reduces oxidation and ensures a fresh, gourmet taste with every brew. VitaCup products are available now for purchase on VitaCup.com in 16- to 28-count multipacks, ranging from $25-$150. Corporate rates are offered for bulk orders. VitaCup plans to launch new formulations and flavors later this year. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/new-company-vitacup-launches-offering-vitamin-infused-coffee-and-tea-for-keurig-systems-300443817.html
News Article | May 2, 2017
News Article | May 2, 2017
President Donald Trump has praised China for its help in pressuring North Korea, while softening his stance on trade and other issues with the Asian giant (AFP Photo/Brendan Smialowski) Washington (AFP) - US President Donald Trump said Monday he would be "honored" to meet North Korean leader Kim Jong-Un under the right conditions, in comments that contrasted with earlier threats of military action. As Pyongyang threatens to carry out a sixth nuclear test that would further inflame tensions, Trump appeared to offer the prospect of a diplomatic off-ramp. "If it would be appropriate for me to meet with him I would, absolutely. I would be honored to do it," Trump said in an interview with Bloomberg. "If it's under the, again, under the right circumstances. But I would do that," Trump said. South Korean analysts said the US president was "groping for an exit" after weeks of heightened tensions over the North's weapons ambitions. In recent weeks Trump has threatened and berated the regime, fearing it may be months away from marrying nuclear and long-range missile technology --- making a strike against the western United States possible. Trump's main gambit has been to encourage China to use its leverage to pressure Pyongyang -- a strategy that has failed to produce results in the past. The Republican president has also said he is ready to act alone in the stand-off, however -- and on Monday signaled that this could involve face-to-face talks with Kim, who has yet to meet a foreign leader since taking power. "Following weeks of huffing and puffing, Trump is apparently groping for an exit," said Hong Hyun-Ik of Sejong University in Seoul. "True to his mentality as a businessman, he has driven the situation close to the edge but stopped short of pushing it over the cliff in order to get the upper hand in future negotiations. " In the latest rhetoric to fuel jitters across the region, North Korea -- which has carried out five nuclear tests in the last 11 years -- warned Monday that it was prepared to carry out another test "at any time and at any location" set by its leadership. The regime will continue bolstering its "preemptive nuclear attack" capabilities unless Washington scraps its hostile policies, a spokesman for the North's foreign ministry said in a statement carried by the state-run KCNA news agency. "The DPRK's measures for bolstering the nuclear force to the maximum will be taken in a consecutive and successive way at any moment and any place decided by its supreme leadership," the spokesman added, apparently referring to a sixth nuclear test and using the North's official name, the Democratic People's Republic of Korea. Pyongyang intensifies its warnings every spring, when Washington and Seoul carry out joint exercises it condemns as rehearsals for invasion. But this time fears of conflict have been fueled by a cycle of threats from both sides. The joint drills have just ended, but naval exercises are continuing in the Sea of Japan (East Sea) with a US strike group led by the aircraft carrier USS Carl Vinson, and US B1-B bombers carried out bilateral missions with South Korean and Japanese aircraft in the region Monday. CIA director Mike Pompeo was in South Korea on an unannounced visit Monday as tensions mount on the peninsula. Pompeo's visit coincided with news that the controversial US missile defense system known as THAAD -- whose deployment has angered China -- was operational in South Korea. US Forces Korea said THAAD was "operational and has the ability to intercept North Korean missiles and defend the Republic." Trump on Sunday repeated his determination to resolve the threat posed by North Korea, warning in a CBS interview: "We cannot let what's been going on for a long period of years continue." But the US leader also offered some backhanded praise for Kim, saying he had faced a formidable challenge in taking over the country at a reported age of 27 after his father's death in 2011. "He's dealing with obviously very tough people, in particular the generals and others. And at a very young age, he was able to assume power," Trump said on CBS's "Face the Nation." "So obviously, he's a pretty smart cookie," he said. That comment left the White House struggling to downplay Trump's apparent admiration. "His point was he assumed power at a young age when his father passed away and there's a lot of potential threats that could have come his way and he's obviously managed to lead a country forward,” said Press Secretary Sean Spicer.
News Article | March 1, 2017
Blast Your Drink, LLC has announced it is partnering with NutriFusion® to add twelve essential vitamins from twelve fruits and vegetables to their latest products, Fresh Blast and Vita-Dog. Both products are multivitamin water brands intended for the healthy consumer and pet markets. Fresh Blast utilizes dosing cap technology, or Blast cap technology, to store the natural vitamins and flavors in the cap of the drink. When a consumer is ready to drink their Fresh Blast, they simply peel off the security seal, turn the cap and pound the top of the cap downward, Blasting the all-natural nutrition into the water below. Consumers then shake the bottle for a few seconds and enjoy the most natural multi-vitamin water in the world. “We were focused on developing a healthy beverage that sourced natural vitamins from fruits and vegetables instead of synthetic vitamins like most other drinks use,” says CEO of Fresh Blast, Bruce Bonham. “We believe our Fresh Blast Multivitamin Water is perfect for kids and adults that want a healthy beverage with real vitamins that tastes delicious!” NutriFusion, LLC has been producing fruit and vegetable based nutrient blends for food, beverage, supplement, and pet brands since 2008. The partnership with Fresh Blast showcases the uniqueness of the GrandFusion® Twelve Fruit and Vegetable Vitamin Blend. With GrandFusion®, Fresh Blast delivers 12.5% RDA of 12 vitamins per 10 ounce serving including Vitamin A, Vitamin C, Vitamin D, Vitamin E, Vitamin K, Vitamin B1 (Thiamine), Vitamin B2 (Riboflavin), Vitamin B3 (Niacin), Vitamin B5 (Pantothenic Acid), Vitamin B6, Vitamin B7 (Biotin), Vitamin B9 (Folate). Myra Mackey, Executive Vice President at NutriFusion®, had this to say, “We are excited to see a multivitamin water using GrandFusion® real food nutrition. The Fresh Blast flavor profiles (Lemon Ginger, Strawberry Banana, Mango Peach, and Coconut) are all fantastic! They put together a complete, healthy beverage with only 1 gram of sugar, 1 carb, 12 vitamins, and only 5 calories. As more brand partners add our nutrients, we hope to see consumers demand companies switch from synthetic alternatives.” To learn more about Fresh Blast and NutriFusion® products or to book an interview, contact Eric Dunn at Digerati Marketing. NutriFusion® was formed in 2008 and is headquartered in Naples, FL and provides the nutrient-rich benefits of fruits and vegetables in everyday food and beverage products. NutriFusion® sources only whole, organic, Non-GMO foods to create its concentrated micronutrient and phytonutrient-rich food ingredient blends. GrandFusion®, a patented blend of fruits and/or vegetables can significantly increase the nutritional profile and marketability of food, beverage and supplement products. NutriFusion® uses only fresh food, never synthetic additives, excipients, preservatives, or synthetic ingredients. About Blast Your Drink, LLC – http://www.freshblast.info and http://www.vita-dog.info Blast Your Drink, LLC was founded by Bruce Bonham to create the world’s first natural multivitamin water. Since starting the company, they have developed two brands, Fresh Blast and Vita-Dog, to bring multivitamin water to the consumer beverage and pet markets. Fresh Blast will be available for viewing in Engredea at Expo West in the NutriFusion Booth #315.